1. Metformin influences progression in diabetic glioblastoma patients
    Sebastian Adeberg et al, 2015, Strahlentherapie und Onkologie CrossRef
  2. Metformin enhances radiosensitivity in hepatocellular carcinoma by inhibition of specificity protein 1 and epithelial-to-mesenchymal transition
    Tian-Ren Huang et al, 2019, Journal of Cancer Research and Therapeutics CrossRef
  3. Nanomedicine‐Enabled Modulation of Tumor Hypoxic Microenvironment for Enhanced Cancer Therapy
    Jinping Wang et al, 2020, Advanced Therapeutics CrossRef
  4. Recent Research on Methods to Improve Tumor Hypoxia Environment
    Xiao-Hua Zhu et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
  5. Niclosamide enhances the antitumor effects of radiation by inhibiting the hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway in human lung cancer cells
    Mei Xiang et al, 2017, Oncology Letters CrossRef
  6. Concentration‐dependent metabolic effects of metformin in healthy and Fanconi anemia lymphoblast cells
    Silvia Ravera et al, 2018, Journal of Cellular Physiology CrossRef
  7. In Vivo and In Vitro Effects of ATM/ATR Signaling Pathway on Proliferation, Apoptosis, and Radiosensitivity of Nasopharyngeal Carcinoma Cells
    Ming Wang et al, 2017, Cancer Biotherapy and Radiopharmaceuticals CrossRef
  8. Liposomes co-loaded with metformin and chlorin e6 modulate tumor hypoxia during enhanced photodynamic therapy
    Xuejiao Song et al, 2017, Nano Research CrossRef
  9. Role of metformin on base excision repair pathway in p53 wild-type H2009 and HepG2 cancer cells
    Irem Dogan Turacli et al, 2018, Human & Experimental Toxicology CrossRef
  10. Metformin enhances the radiosensitivity of human liver cancer cells to γ-rays and carbon ion beams
    Eun Ho Kim et al, 2016, Oncotarget CrossRef
  11. Molecular determinants of radiosensitivity in normal and tumor tissue: A bioinformatic approach
    Athanasia Pavlopoulou et al, 2017, Cancer Letters CrossRef
  12. Metformin: (future) best friend of the radiation oncologist?
    Benjamin Chevalier et al, 2020, Radiotherapy and Oncology CrossRef
  13. Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus
    Chin-Hsiao Tseng, 2018, Metabolism CrossRef
  14. A New Series of Cytotoxic Pyrazoline Derivatives as Potential Anticancer Agents that Induce Cell Cycle Arrest and Apoptosis
    Hong Wang et al, 2017, Molecules CrossRef
  15. Senolytics and senostatics as adjuvant tumour therapy
    Susan Short et al, 2019, EBioMedicine CrossRef
  16. Transcriptomic landscape profiling of metformin‐treated healthy mice: Implication for potential hypertension risk when prophylactically used
    Yuhong Meng et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
  17. Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
    Panagiota Papanagnou et al, 2016, Pharmaceuticals CrossRef
  18. Effects of different combined regimens of cisplatin, metformin, and quercetin on nasopharyngeal carcinoma cells and subcutaneous xenografts
    Zhongwei Chen et al, 2021, Scientific Reports CrossRef
  19. Radiation-Induced Glycogen Accumulation Detected by Single Cell Raman Spectroscopy Is Associated with Radioresistance that Can Be Reversed by Metformin
    Quinn Matthews et al, 2015, PLOS ONE CrossRef